SHAPE is a non-profit medical organization dedicated to the mission of eradicating heart attacks. Learn more…
Letter to the New Director of Medicare Program Re: Coronary Artery Calcium Score Coverage
Progress in the Integrated Care of Screen-Identified Disease: Lung Cancer and Coronary Artery Diseases
Morteza Naghavi, MD, Society for Heart Attack Prevention and Eradication (SHAPE)
Mayo Clinic Cardiovascular Grand Round
“Machine Learning Asymptomatic Vulnerable ASCVD Patients;
Predicting Heart Attacks like Hurricanes”
Morteza Naghavi, M.D.
Founder and President of SHAPE (Society for Heart Attack Prevention and Eradication)
For the First Time in United States CMS (Center for Medicare and Medicaid Services) Receives a Formal Proposal from SHAPE Doctors for National Coverage Determination (NCD) for Coronary Artery Calcium Score Coverage
Leading cardiologists and cardiovascular researchers praised this effort as a historical bold move that was long due.
Morteza Naghavi, M.D., David Maron, M.D., Robert Kloner, M.D., Ph.D., Daniel Berman, M.D., Mathew Budoff, M.D., Robert Superko, M.D., P.K. Shah, M.D.
SAVE THE DATE!
SHAPE President Welcomes Addition of Coronary Calcium Scanning to New AHA/ACC Heart Disease Prevention Guidelines Calls It “A Long Time Coming”
Doctors Request CNN to Correct Disinformation Quoted from
Dr. Nissen; Coronary Calcium Scan Costs <$200 Not “$800-$1,000”
The 2nd Machine Learning Vulnerable Patient Symposium
Focused on Developing an
Artificial Intelligence-based Forecast System for Short-Term CVD Events
A Satellite Event in Conjunction with
2017 Annual Scientific Sessions of American Heart Association
November 13, 7-10 PM
SHAPE Leaders Invite Cardiology Clinics to Participate in TACT-II CAC Study
In a letter to SHAPE-Centers of Excellence and other prominent cardiologists, Drs. Naghavi, Budoff, Maron and Berman announced an exciting hypothesis to be tested in TACT-II CAC sub-study which if proven can change the way millions of patients are treated for prevention of heart attacks. Learn more…
The First Machine Learning Vulnerable Patient Symposium
A Focus Group Meeting on Developing an Artificial Intelligence-based Forecast System for Prediction of Heart Attacks within 12 Months
A Satellite Event in Conjunction with
2016 Annual Scientific Sessions of American Heart Association
Le Meridien Hotel, New Orleans, LA
November 14, 7-10 PM
Featured Coverage of SHAPE Guidelines Release
Featured Presentations from the 2004 Vulnerable Patient Symposium
A Satellite Event during the Annual Scientific Sessions of American College of Cardiology 2004, New Orleans
12 years have passed since this symposium and SHAPE is still searching for the answers to these questions: “How can we detect the Vulnerable Patients before a heart attack? and how can we save them?“
Eugene Braunwald, M.D. – Harvard Medical School, Boston, USA
Douglas Zipes, M.D. – Indiana University, Indianapolis, USA
Valentin Fuster, M.D., Ph.D. – Mount Sinai Hospital, New York, USA
CT / MRI for Risk Stratification and Identification of the Vulnerable Patient Transcript (PDF)
Attilio Maseri, M.D. – Universita Vita-Salute San Raffaele, Milan, Italy
From Vulnerable Plaque to Vulnerable Patient—Part III: SHAPE Guidelines
From Vulnerable Plaque to Vulnerable Patient
In 2001, Dr. Naghavi, the founder of SHAPE invited cardiology leaders to answer these 10 questions. Now, after 15 years it is interesting to review their answers and compare the predictions with reality. Click here to view
SHAPE Congratulates Dr. MacRae and Team for Winning the $75 Million One Brave Idea Award To End Coronary Heart Disease
The 10th annual Golf Fore Heart Tournament at the Mountain Branch Golf Club in Joppa, MD took place on June 22, 2016. The event was organized by JoAnne Zawitoski, the chairwoman of SHAPE and Mark Montgomery who co-chaired the event in the past 10 years. Read more…
Since the SHAPE movement roots in the early days of “Vulnerable Plaque” era, on behalf of the SHAPE Task Force, I would like to bring the following to your attention. Read more…
Leading cardiovascular physicians and researchers gathered at SHAPE Trial Advisory meeting to chart the course for perfecting early detection of patients vulnerable to heart attack Read more The SHAPE Trial Advisory Meeting, August 21-23, 2015, Los Angeles – Marina del Ray, CA Ritz-Carlton Hotel, Marina Vista Conference Room
Day 1: Necessity, Feasibility, Design, Implementation, and Fundraising for a Longitudinal Outcome Study to Compare SHAPE Guidelines with the Status Quo Day 2: Public Healthcare Policies and Regulatory Initiatives, SHAPE Centers of Excellence.
* ***The SHAPE Trial Advisory Meeting – Part II***
A satellite event in conjunction with 2015 Annual Scientific Sessions of American Heart Association – Rosen Plaza Hotel, Orlando, FL Nov 9th, 2015, 7 pm – 9 pm PST (Dinner will be served) –View Agenda
The Latest on Coronary Calcium and Carotid/Femoral Plaque-Based Risk Assessment for Early Detection and Treatment of Atherosclerotic Cardiovascular Disease Nov 4th, 2015, 10 am – 12 noon PST View Agenda Click here to watch recorded webinar!
SHAPE Accredited Centers of Excellence
The SHAPE Accredited Centers Of Excellence Program Is A Scientifically Validated And Guideline-Based Approach To Early Detection Of Coronary Artery Disease.
Six Additional East Texas Medical Center Hospitals Certified as SHAPE Centers of Excellence
A major step toward improving patient outcomes through early detection and prevention of coronary artery disease the number 1 killer….. Read more
The SHAPE Accredited Centers of Excellence program is a scientifically validated and guideline-based approach to early detection of Coronary Artery Disease.
SHAPE Applauds U.S. Preventive Services Task Force for Seeking the Truth about Coronary Artery Calcium
Commentary by Professor Raimund Erbel
Remembering SHAPE Volunteer:
Become a SHAPE Certified Provider
[contact-form-7 id=”23740″ title=”Contact form 1″]
Click below to order SHAPE BOOK
[feedzy-rss feeds="https://newsroom.heart.org/rss.xml" max="5" summarylength="100" feed_title="no" thumb="no"]
Arthur Agatston, M.D., Dan Arking, Ph.D., Juan J. Badimon, Ph.D., Raymond D. Bahr, MD,Daniel Berman, M.D., Roger Blumenthal, M.D. Matthew Budoff, M.D., Jay N. Cohn, M.D., Michael Davidson, M.D., James E. Ehrlich, M.D., Raimund Erbel, M.D., Erling Falk, M.D., Ph.D., Zahi A. Fayad, Ph.D., Sergio Fazio, M.D., Ph.D., Steve Feinstein, M.D., Valentin Fuster, M.D., Ph.D., Craig J. Hartley, Ph.D., Harvey S. Hecht, M.D., Howard Hodis, M.D., Ioannis A. Kakadiaris, Ph.D. , Sanjay Kaul, M.D., M.P.H., Asher Kimchi, MD, Wolfgang Koenig, M.D., Ph.D., Iftikhar J. Kullo, M.D., Daniel Lane, M.D., Ph.D., Roxana Mehran, M.D., Ralph Metcalfe, Ph.D., Morteza Naghavi, M.D., Tasneem Naqvi, M.D., Jagat Narula, M.D., Khurram Nasir, M.D., M.P.H., Paolo Raggi, M.D., George P. Rodgers, M.D., James HF Rudd, Ph.D., John A. Rumberger, Ph.D., M.D., Robert S. Schwartz, M.D., PK Shah, M.D., Leslee J. Shaw, Ph.D., Henrik Sillesen, M.D., D.MSc., J. David Spence, M.D., H. Robert Superko, M.D., Allen Taylor, M.D., PJ Touboul, M.D. View SHAPE Scientific Advisors